ww glp 1 cost How Employers Can Manage GLP-1 Costs in Their Health Plans Wellness Wednesday: What's the Deal

Novo is not alone in investing in combination approaches: in AstraZenecas 2023 announcement of its acquisition of Eccogenes GLP-1 program, the manufacturer noted that they intend to combine the GLP-1 asset with other products in their portfolio (e.g., Farxiga, baxdrostat) in an effort to address obesity comorbidities (e.g., heart disease, kidney disease, metabolic syndrome)

De Jonghe

Jonathan E

Both are GLP-1 agonists, but are synthesized differently

"Gastrointestinal toxicities tended to occur early after treatment initiation with fluctuation over time, both in a type 2 diabetic population and a more general population." Lulu Liu, Researcher, West China Second University Hospital Theres a noticeable difference between short-acting and long-acting formulations